Anti-Human CTLA4 Therapeutic Antibody Fab Fragment (TGN2122.H)

This antibody is a CTLA-4-specific agonistic monoclonal antibody which may stimulate of CTLA-4 and may be used in the treatment of a disease selected from the group consisting of rheumatoid arthritis, type I diabetes, multiple sclerosis, systemic lupus erythematosus, psoriasis, ulcerative Ulerosa, Crohn's disease and so on.
Supplier Creative Biolabs
Product # TAB-083MZ-F(E)
Pricing Inquiry
Type Humanized antibody
Applications Enzyme-linked Immunosorbent Assay, Flow Cytometry
Host Human
Target CTLA-4 (Cytotoxic T lymphocyte antigen-4)
Feedback